Lees AJ, Hardy J, Revesz T. Parkinson’s disease. Lancet. 2009;373:2055–66. https://doi.org/10.1016/S0140-6736(09)60492-X.

Article  CAS  PubMed  Google Scholar 

Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386:896–12. https://doi.org/10.1016/S0140-6736(14)61393-3.

Article  CAS  PubMed  Google Scholar 

Marras C, Canning CG, Goldman SM. Environment, lifestyle, and Parkinson’s disease: implications for prevention in the next decade. Mov Disord. 2019;34:801–11. https://doi.org/10.1002/mds.27720.

Article  PubMed  Google Scholar 

Agnihotri A, Aruoma OI. Alzheimer’s disease and Parkinson’s disease: a nutritional toxicology perspective of the impact of oxidative stress, mitochondrial dysfunction, nutrigenomics and environmental chemicals. J Am Coll Nutr. 2020;39:16–27. https://doi.org/10.1080/07315724.2019.1683379.

Article  CAS  PubMed  Google Scholar 

Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson’s disease. Front Aging Neurosci. 2014;6:36. https://doi.org/10.3389/fnagi.2014.00036.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, et al. The gut-brain axis in Parkinson’s disease: possibilities for food-based therapies. Eur J Pharm. 2017;817:86–95. https://doi.org/10.1016/j.ejphar.2017.05.042.

Article  CAS  Google Scholar 

Strikwerda AJ, Dommershuijsen LJ, Ikram MK, Voortman T. Diet quality and risk of Parkinson’s disease: the Rotterdam Study. Nutrients. 2021;13:3970. https://doi.org/10.3390/nu13113970.

Article  PubMed  PubMed Central  Google Scholar 

Alfonsetti M, Castelli V, d’Angelo M. Are we what we eat? Impact of diet on the gut-brain axis in Parkinson’s disease. Nutrients. 2022;14:380. https://doi.org/10.3390/nu14020380

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castelli V, Benedetti E, Antonosante A, Catanesi M, Pitari G, Ippoliti R, et al. Neuronal cells rearrangement during aging and neurodegenerative disease: metabolism, oxidative stress and organelles dynamic. Front Mol Neurosci. 2019;12:132. https://doi.org/10.3389/fnmol.2019.00132.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barichella M, Cereda E, Cassani E, Pinelli G, Iorio L, Ferri V, et al. Dietary habits and neurological features of Parkinson’s disease patients: implications for practice. Clin Nutr. 2017;36:1054–61. https://doi.org/10.1016/j.clnu.2016.06.020.

Article  PubMed  Google Scholar 

Liddle RA. Parkinson’s disease from the gut. Brain Res. 2018;1693:201–6. https://doi.org/10.1016/j.brainres.2018.01.010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castelli V, Grassi D, Bocale R, d’Angelo M, Antonosante A, Cimini A, et al. Diet and brain health: which role for polyphenols? Curr Pharm Des. 2018;24:227–38. https://doi.org/10.2174/1381612824666171213100449.

Article  CAS  PubMed  Google Scholar 

Talebi S, Ghoreishy SM, Jayedi A, Travica N, Mohammadi H. Dietary antioxidants and risk of Parkinson’s disease: a systematic review and dose-response meta-analysis of observational studies. Adv Nutr. 2022;13:1493–504. https://doi.org/10.1093/advances/nmac001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928.

Article  PubMed  PubMed Central  Google Scholar 

Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64:401–6. https://doi.org/10.1016/j.jclinepi.2010.07.015.

Article  PubMed  Google Scholar 

Zhou H, Ye M, Xu W, Yu M, Liu X, Chen Y. DL-3-n-butylphthalide therapy for Parkinson’s disease: a randomized controlled trial. Exp Ther Med. 2019;17:3800–6. https://doi.org/10.3892/etm.2019.7397.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Storch A, Jost WH, Vieregge P, Spiegel J, Greulich W, Durner J, et al. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Arch Neurol. 2007;64:938–44. https://doi.org/10.1001/archneur.64.7.nct60005.

Article  PubMed  Google Scholar 

Barichella M, Cereda E, Pinelli G, Iorio L, Caroli D, Masiero I, et al. Muscle-targeted nutritional support for rehabilitation in patients with Parkinsonian syndrome. Neurology. 2019;93:e485–96. https://doi.org/10.1212/WNL.0000000000007858.

Article  CAS  PubMed  Google Scholar 

Baroni L, Bonetto C, Tessan F, Goldin D, Cenci L, Magnanini P, et al. Pilot dietary study with normoproteic protein-redistributed plant-food diet and motor performance in patients with Parkinson’s disease. Nutr Neurosci. 2011;14:1–9. https://doi.org/10.1179/174313211X12966635733231.

Article  CAS  PubMed  Google Scholar 

Anamnart C, Kitjarak R. Effects of vitamin B12, folate, and entacapone on homocysteine levels in levodopa-treated Parkinson’s disease patients: a randomized controlled study. J Clin Neurosci. 2021;88:226–31. https://doi.org/10.1016/j.jocn.2021.03.047.

Article  CAS  PubMed  Google Scholar 

Cereda E, Pinelli G, Iorio L, Caroli D, Masiero I, Ferri V, et al. Protein, leucine and vitamin D enhancing rehabilitation (pro-leader) in patients with Parkinson’s disease or parkinsonism: a randomized clinical trial. Clin Nutr. 2018;37:S25. https://doi.org/10.1016/j.clnu.2018.06.2101.

Article  Google Scholar 

Clemens P, Baron JA, Coffey D, Reeves A. The short-term effect of nicotine chewing gum in patients with Parkinson’s disease. Psychopharmacology. 1995;117:253–6. https://doi.org/10.1007/BF02245195.

Article  CAS  PubMed  Google Scholar 

Coe S, Andreoli D, George M, Collett J, Reed A, Cossington J, et al. A feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue and fatigability in people with Parkinson’s (pwP). Clin Nutr ESPEN. 2022;48:68–73. https://doi.org/10.1016/j.clnesp.2022.01.023.

Article  CAS  PubMed  Google Scholar 

Cucca A, Mazzucco S, Bursomanno A, Antonutti L, Di Girolamo FG, Pizzolato G, et al. Amino acid supplementation in l-dopa treated Parkinson’s disease patients. Clin Nutr. 2015;34:1189–94. https://doi.org/10.1016/j.clnu.2014.12.007.

Article  CAS  PubMed  Google Scholar 

Taghizadeh M, Tamtaji OR, Dadgostar E, Daneshvar Kakhaki R, Bahmani F, Abolhassani J, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson’s disease: a randomized, double-blind, placebo-controlled trial. Neurochem Int. 2017;108:183–9. https://doi.org/10.1016/j.neuint.2017.03.014.

Article  CAS  PubMed  Google Scholar 

Hiller AL, Murchison CF, Lobb BM, O’Connor S, O’Connor M, Quinn JF. A randomized, controlled pilot study of the effects of vitamin D supplementation on balance in Parkinson’s disease: does age matter? PLoS ONE. 2018;13:e0203637. https://doi.org/10.1371/journal.pone.0203637.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, et al. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014;71:543–52. https://doi.org/10.1001/jamaneurol.2014.131.

Article  PubMed  Google Scholar 

Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004–13. https://doi.org/10.3945/ajcn.112.051664.

Article  CAS  PubMed  Google Scholar 

Chahra C, Anis H, Bissene D, Mejda S, Jihène M, Salma N, et al. The effect of Origanum majorana tea on motor and non-motor symptoms in patients with idiopathic Parkinson’s disease: a randomized controlled pilot study. Parkinsonism Relat Disord. 2021;91:23–7. https://doi.org/10.1016/j.parkreldis.2021.08.013.

Article  CAS  PubMed  Google Scholar 

Oliveira GS, Iraci L, Pinheiro GS, Casal MZ, Haas AN, Pochmann D, et al. Effect of exercise and grape juice on epigenetic modulation and functional outcomes in PD: a randomized clinical trial. Physiol Behav. 2020;227:113135. https://doi.org/10.1016/j.physbeh.2020.113135.

Article  CAS  PubMed  Google Scholar 

Wolz M, Schleiffer C, Klingelhöfer L, Schneider C, Proft F, Schwanebeck U, et al. Comparison of chocolate to cacao-free white chocolate in Parkinson’s disease: a single-dose, investigator-blinded, placebo-controlled, crossover trial. J Neurol. 2012;259:2447–51. https://doi.org/10.1007/s00415-012-6527-1.

Article  CAS  PubMed  Google Scholar 

Cilia R, Laguna J, Cassani E, Cereda E, Raspini B, Barichella M, et al. Daily intake of Mucuna pruriens in advanced Parkinson’s disease: a 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord. 2018;49:60–6. https://doi.org/10.1016/j.parkreldis.2018.01.014.

Article  PubMed